S&P Biotech SPDR (XBI)

The buyers are in charge of the healthcare stocks this year. And judging from their charts, these stocks and ETFs in particular offer great opportunities.

First-Mover Advantage Will Benefit Amarin Stock More Than You Think

By Ian Cooper Feb 24, 2020

There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.

3 Top Drug Stocks to Own In 2020

By Ian Cooper Jan 3, 2020

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

4 Top Stock Trades for Friday: MU, Biotech, Bitcoin

By Bret Kenwell, InvestorPlace Contributor Sep 26, 2019

Bitcoin, Biotech, Micron and Starbucks were our top stock trades to watch. Here's how the charts are setting up going into Friday.

Hexo Stock Is Down — But Not Out

By Nicolas Chahine, InvestorPlace Contributor Sep 4, 2019

HEXO stock is down 50% since the end of April. But inside this support zone, the bulls can mount a 20% rally if headlines cooperate.

7 Biotech ETFs That Should Remain Healthy

By Todd Shriber, InvestorPlace Contributor Aug 5, 2019

The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.

7 of the Best SPDR ETFs — Besides SPY and GLD

By Todd Shriber, InvestorPlace Contributor Jul 3, 2019

SPDR ETFs span an array of asset classes, including stocks, bond, commodities and real estate, among others. Here are 7 of the best ETFs to buy from SPDR.

Nasdaq Today: iQiyi Surges on Award; Intel, Cisco Struggle

By Bret Kenwell, InvestorPlace Contributor Jun 27, 2019

Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.

IBB is up Over 5%, But the Market May Retest its Lows

By Ken Trester Jan 7, 2019

This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

7 Biotech ETFs to Consider for 2019

By Todd Shriber, InvestorPlace Contributor Nov 20, 2018

Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.

10 Best ETFs for 2018: Still a Close Race at the Head of the Pack

By Jessica Loder, InvestorPlace Assistant Editor Oct 10, 2018

As the Best ETFs contest enters its final quarter, there are a few contenders that could reasonably take the trophy for 2018.

10 Best ETFs for 2018: Biotechs Top the Charts at the Midpoint

By Jessica Loder, InvestorPlace Assistant Editor Jul 11, 2018

As our Best ETFs for 2018 contest crosses into the second half of the year, a few contestants are really making standout gains, but others are making strong moves.